CCS Becomes First Chronic Care Management Organization To Deploy Enterprise-Wide Agentic AI To Better Serve the Complex Patient Journey

CCS’s AI platform, CeeCee™, is projected to save more than 30% in annual operating costs while autonomously resolving routine patient interactions and accelerating access to chronic care supplies

ST. PETERSBURG, Fla.--(BUSINESS WIRE)--CCS, a leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions, today announced it has become the first chronic care management organization to deploy agentic AI in a comprehensive way across its enterprise operations. Investment in these advanced tools helps streamline the patient experience, particularly during challenging times when an individual may be facing insurance changes, benefit shifts, and/or manufacturer inventory shortages.

Unlike what we are seeing across the industry — where reality has not yet caught up with the AI euphoria as most AI implementations are still at pilot-scale — CCS has already designed, developed, and deployed a comprehensive and enterprise-wide agentic AI platform. This platform better serves complex patients at scale with measurable positive impact, including savings of more than 30% in annual operating costs.

“CCS is demonstrating an innovative approach to AI in healthcare,” said Bill Fera, MD, GenAI Health and Life Sciences Lead at Deloitte. “By deploying a sophisticated multi-agent network across its entire operation, CCS is transforming how patients with complex care needs are supported in its business — autonomously handling interactions, accelerating care delivery, and improving operational efficiency.”

CeeCee™ Delivering Immediate Chronic Care Impact

CeeCee™ — CCS’s agentic AI solution — represents a fundamentally different approach to healthcare AI adoption. Unlike many current AI models, CeeCee™ is trained on CCS’s own proprietary knowledge and data to deliver empathetic, personalized support that resonates with the chronic care population the company serves.

The platform is projected to autonomously contain 25% of relevant incoming calls in the initial four months, while reducing call handling times across all interactions — resulting in improved patient experience while supporting the real-time needs of frontline teams. In addition to CeeCee™, the broader enterprise AI platform from CCS also includes:

• Autonomous Documentation Gap Closure – CCS’s AI platform works behind the scenes with healthcare provider offices to autonomously identify and close documentation gaps that delay referrals or reorders for patients waiting for continuous glucose monitor (CGM) or insulin pump supplies. By the end of 2026, this capability is expected to automatically process 70%–80% of the more than 100,000 monthly intake documents, accelerating order fulfillment and getting patients on therapy weeks sooner.
• Real-Time Intelligence for Complex Cases – When patient needs exceed CCS’s autonomous capabilities, the AI instantly surfaces consolidated patient profiles, call history, and clinical context for human agents — eliminating the need to navigate across disconnected systems. This consolidation reduces average customer service call handle time by up to 20%, enabling care teams to focus exclusively on complex patient needs rather than juggling back-end administrative work.

“CCS’s platform shows how AI can deliver tangible results at scale today. This is a new level of integration and patient-centric design that is rare — even amid rapid AI advancements happening today, especially in healthcare,” said Jean-Claude Saghbini, President at Lumeris Technology Solutions and technology advisor for CCS.

From Predictive AI to Fully Agentic Operations

CCS’s agentic AI deployment builds on the company’s proven track record of AI-driven results. In 2024, CCS launched PropheSee™, a predictive analytics and intervention platform that generated more than $10 million in Medicare savings by proactively addressing CGM nonadherence in thousands of Medicare patients with diabetes.

While PropheSee™ focuses externally on patient adherence and outcomes, CeeCee™ drives advances in patient workflows and experience, along with internal operational excellence and efficiency — creating a comprehensive AI ecosystem that is redefining chronic care management from patient engagement through care delivery.

“CeeCee™ and our broader agentic AI platform aren’t pilots or a proof of concept — they are enterprise-grade solutions operating across our entire organization right now, autonomously handling patient interactions, accelerating care delivery, and freeing our teams to focus on what they do best: providing compassionate, personalized support for complex chronic patient needs,” said Richard Mackey, Chief Technology Officer at CCS.

CCS’s approach to enterprise AI adoption is focused on defragmenting the complex patient experience while driving improved chronic care outcomes at lower total cost of care. The company’s enterprise AI strategy prioritizes responsible implementation with strict adherence to healthcare privacy, security, and compliance standards — and is built on security-by-design architecture including zero-trust protocols, encryption, and automated vulnerability scanning.

For more information on CeeCee™, CCS’s enterprise AI platform, please visit www.ccsmed.ai.

About CCS Medical

CCS is the strategic partner addressing America’s most pressing healthcare challenges through intelligent chronic care management, tackling the $412 billion annual diabetes burden and chronic conditions affecting over 133 million Americans. At the core of CCS’s differentiated model is LivingConnected®, a human-led, digitally enabled clinical solution. PropheSee™ — an AI-powered predictive model that identifies nonadherence risk and delivers personalized interventions — is an integral part of this solution, creating a first-of-its-kind platform to improve adherence, enhance clinical outcomes, and help prevent costly hospitalizations. By combining data-driven insights with three decades of industry relationships, CCS is the smart choice for health plans, providers, employers, and manufacturers who believe that value-based care starts by keeping patients healthy and delivers benefits like lower cost of care, improved HEDIS scores, and alleviating provider burnout. CCS’s approach extends clinical reach while supporting over 200,000 people nationwide with home-delivered medical supplies and pharmaceuticals annually. Recognized as a Great Place to Work® and with several peer-reviewed publications validating our care management approach, CCS is more than a trusted supplier — we’re a partner in transforming chronic care delivery. To learn more about how CCS is addressing today’s healthcare challenges, visit CCSMed.com or connect with us on LinkedIn.